Featured Research

from universities, journals, and other organizations

New Firefly technology lights up more precise kidney sparing surgery

Date:
June 5, 2012
Source:
MedStar Georgetown University Hospital
Summary:
During kidney surgery, Firefly fluorescence used with the da Vinci robot lights up in "firefly green" the blood supply to the kidney and helps differentiate cancerous from healthy tissue. More patients can keep the healthy part of their kidney rather than losing the entire organ.

A surgical technology called Firefly is shedding new light on kidney cancers and helping doctors at MedStar Georgetown University Hospital remove tumors more safely and more efficiently while sparing the rest of the healthy kidney.

"The addition of Firefly fluorescence during robotic surgery improves our ability to remove kidney tumors when before we might have had to remove the whole kidney," said Keith Kowalczyk, MD, urologist and robotic surgeon. "Firefly, which essentially utilizes a dye that lights up in "firefly green" when using a specialized fluoroscopic camera, can show us the difference between cancerous and healthy tissue and helps us see the blood supply to the tumor. It lights up parts of the kidney and its blood supply we couldn't see this well before."

This new innovation uses the minimally-invasive precision of the da Vinci Surgical System, and adds the second component of Firefly fluorescence imaging. MedStar Georgetown is one of the first hospitals in the DC region to use this new technology.

When Eugene Carter of Washington, D.C. was diagnosed with kidney cancer, the decision to have robotic surgery by Dr. Kowalczyk while utilizing fluorescence imaging seemed the obvious choice.

"I'm 70, and with advanced age the hazards of surgery can increase, so I wanted the least invasive surgery possible," explained Mr. Carter. "The robotics provide more steadiness and precision, and I wanted my surgeon to be as steady and as precise as possible. It seems to me this is just a much wiser system."

How does it work? The Firefly technology uses near-infrared imaging to detect an injected tracer dye of indocyanine green (ICG) in the blood.

During surgery, urologists use the Firefly system at three different stages of the procedure. The first injection of the dye into the IV by the anesthesiologist gives a detailed picture of the blood supply to the kidney.

"Up to 25-percent of patients might have extra renal arteries that are not always obvious on a CT scan or MRI, so the Firefly can help us see these arteries. This helps us ensure that all of the blood supply to the kidney is accounted for and controlled prior to the removal of the tumor, and can therefore decrease blood loss," explained Dr. Kowalczyk.

The second injection of dye helps the surgeon differentiate between the cancerous tissue and the normal kidney tissue, which can allow for better tumor removal and potentially a lower risk of leaving any cancer behind. Finally, after the tumor has been removed and the kidney has been repaired, the dye can again be injected again to ensure that the blood supply to the kidney has been properly restored.

Besides the known benefits of robotic minimally-invasive surgery -- including smaller incisions, less blood loss, less postoperative pain, shorter hospital stays, and earlier returns to work -- the addition of the Firefly system can improve patient outcomes even further.

"Additionally, the ability to better distinguish between tumor tissue and normal kidney tissue may lead to a lower risk of leaving any tumor behind, and therefore better long-term cancer control," said Dr. Kowalczyk.

According to the American Cancer Society, kidney cancer is among the 10 most common cancers among both men and women. The ACS estimates that about 64,770 new cases of kidney cancer will occur in 2012, and about 13,570 people will die from the disease.

"I'm so glad I was able to keep my kidney," said Mr. Carter. "Without this new system, my kidney might not have been able to be saved."


Story Source:

The above story is based on materials provided by MedStar Georgetown University Hospital. Note: Materials may be edited for content and length.


Cite This Page:

MedStar Georgetown University Hospital. "New Firefly technology lights up more precise kidney sparing surgery." ScienceDaily. ScienceDaily, 5 June 2012. <www.sciencedaily.com/releases/2012/06/120605143424.htm>.
MedStar Georgetown University Hospital. (2012, June 5). New Firefly technology lights up more precise kidney sparing surgery. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/06/120605143424.htm
MedStar Georgetown University Hospital. "New Firefly technology lights up more precise kidney sparing surgery." ScienceDaily. www.sciencedaily.com/releases/2012/06/120605143424.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins